tiprankstipranks
Revance Therapeutics (RVNC)
NASDAQ:RVNC
Holding RVNC?
Track your performance easily

Revance Therapeutics (RVNC) Balance Sheet

624 Followers

Revance Therapeutics Balance Sheet

Revance Therapeutics's total assets for Q3 2024 were $461.56M, a decrease of -6.72% from the previous quarter. RVNC total liabilities were $624.59M for the fiscal quarter, a <0.01% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Assets
$ 478.45M$ 581.90M$ 531.16M$ 720.22M$ 340.29M
Total Liabilities
$ 630.06M$ 569.30M$ 462.69M$ 345.93M$ 114.80M
Total Equity Gross Minority
$ -173.24M$ 12.60M$ 68.47M$ 374.29M$ 225.49M
Total Capitalization
$ 961.77M$ 1.09B$ 925.97M$ 762.49M$ 225.49M
Preferred Stock Equity
-----
Capital Lease Obligations
-----
Currency in USD

Revance Therapeutics Debt to Assets

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis